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Progress Notes 
A Report from the Parkinson's Disease Center at Boston University Medical Center July 1989 
It is with great pleasure that I introduce 
the first newsletter from the American 
Parkinson Disease Information and 
Referral Center at Boston University 
Medical Center. The Information and 
Referral Center has been an important 
part of the Parkinson Program of the 
Department of Neurology for the past 
ten years. Dr. Robert G. Feldman has 
served as Medical Director during this 
time. 
As Coordinator of the Center for the 
past four years, I have recognized the 
need to establish a newsletter to share 
information within the Parkinson com-
munity. This initial newsletter will 
familiarize you with the function of the 
APDA Center, provide medical informa-
tion, describe recent events, and 
provide information on upcoming ac-
tivities. In addition, a column will be 
designated for Chapter and Support 
Groups to exchange information. 
The Roles of the Information 
and Referral Center: 
1^1 Provide educational material 
on Parkinson's disease to patients, fami-
ly members, health care professionals 
and other interested individuals. We 
maintain a library of APDA handbooks, 
books, and video tapes. 
i ; Refer individuals to health care 
professionals, support groups and com-
munity agencies according to special 
needs. 
W Assist in establishing patient 
support groups and provide professional 
input as requested. 
M Increase public awareness of 
Parkinson's disease. 
m Present lectures, conferences and 
symposia on Parkinson's disease to 
patients, families, health care providers 
and social agencies. 
K Assist the Massachusetts 
Chapter with fundraising activities. 
It is my hope that this newsletter 
will be a strong addition to our Center. 
We welcome your contributions and 
suggestions at any time. For further in-
formation call 617-638-8466. 
Sincerely, 
Cathi Thomas, R.N., M.S. 
Coordinator of the APDA Information 
and Referral Center 
MEDICAL UPDATE: 
The Use of Deprenyl 
in Parkinson's Disease 
by Marie Saint-Hilaire, M.D., F R C P C 
Deprenyl is a drug being studied for the 
treatment of Parkinson's disease. It 
was discovered in Hungary in 1964, 
and first used to treat Parkinson's dis-
ease in Europe in 1975. In the United 
States, where Deprenyl is not yet ap-
proved by the Food and Drug Ad-
ministration (FDA), studies are evaluat-
ing two potential uses of this medica-
tion. One use of Deprenyl is as an ad-
juvant to levodopa (Sinemet), and the 
second is to examine the potential ef-
fect of Deprenyl on the progression of 
Parkinson's disease. 
Deprenyl as an adjunct to Sinemet 
Levodopa/carbidopa (Sinemet) is the 
most widely used and accepted treat-
ment of Parkinson's disease. Levodopa 
enters the brain where i t is converted 
into dopamine, the missing transmitter 
in Parkinson's disease. Dopamine is 
then inactivated by an enzyme called 
monoamine oxidase-b (MAO-B). The 
blocking of this enzyme, which normal-
ly inactivates dopamine, would main-
tain desirable levels of dopamine 
produced in the brain by patients 
taking levodopa, and thus increase the 
effectiveness of levodopa. 
Many clinical trials of Deprenyl 
have been carried out, chiefly in 
Europe, where i t has gained acceptance 
as a useful addition to levodopa 
therapy. It has been used mainly in 
patients who have fluctuations in 
mobility when taking Sinemet ("wear-
ing-off" and "on-off" phenomenon), and 
has been found to smooth out mild os-
cillations in about 50 percent of cases. 
In some patients it also increased men-
tal energy and improved attention. It 
is a safe drug in general, but can exacer-
bate a previous stomach ulcer. The 
main reported adverse reactions are re-
lated to an increase in the effects of 
Sinemet leading to nausea, abnormal 
involuntary movements, and con-
fusion. This is why the dose of 
Sinemet often has to be decreased after 
the Deprenyl is started. Finally, i t is 
continued on page 2 
The New Parkinson's 
Day Program at The 
University Hospital 
Responding to a need identified by the 
Parkinson's team in the Department of 
Neurology at Boston University Medi-
cal Center, the Parkinson's Day 
Program was developed and has been 
thriving since last July. This day-long 
program designed for individuals with 
Parkinson's disease and their families 
is another innovative way in which the 
University Hospital at Boston Univer-
sity Medical Center provides out-
patient care services. 
The program was designed specifical-
ly to provide closer physician/nurse 
monitoring of the patient's medication 
response (especially where changes 
have been prescribed) and emphasize 
the Parkinson team's philosophy that 
increasing learning and understanding 
about your condition, including the 
latest research, leads to healthy adjust-
continued on page 2 
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Parkinson's Day 
continued from page 1 
ment, proper management, and 
therapeutic success. With more infor-
mation we feel that a patient be-
comes an active participant in 
his/her care, rather than being a vic-
t i m of Parkinson's disease. 
Admission to the day program is 
made after consultation by 
physicians in the Neurological Refer-
ral Center. In addition to physician 
and nursing observation, activities 
center around aspects of living and 
coping w i t h Parkinson's disease and 
include teaching, discussion, exercise 
demonstrations, counseling, and emo-
tional support services as well as ex-
ercises in enhancing the patient's 
self-concept and continuing social en-
richment. 
The Parkinson's Day Program is 
directed by Dr. Marie Saint-Hilaire, 
who specializes in the treatment of 
movement disorders. Linda Perry, 
R.N., who coordinates the program, 
also has extensive experience work-
ing wi th Parkinson patients as a 
former staff nurse at the Harold and 
Ellen Wald inpatient neurology unit 
at the University Hospital. 
For more information on this 
program please call (617) 266-1565 
or (617) 638-8466. 
Deprenyl 
continued from page 1 
important to emphasize that 
Deprenyl taken without Sinemet has 
no effect on the symptoms of 
Parkinson's disease. 
A 1983 discovery 
In 1983, i t was discovered that a 
chemical by the shorthand name of 
MPTP, which is a contaminant of a 
certain "synthetic heroin", rapidly 
and selectively destroys the same 
group of brain cells that slowly 
degenerate in Parkinson's disease. 
The explosion of research on MPTP-
induced Parkinsonism gave birth to 
the idea that natural Parkinson's dis-
perse vera/years, the Harold and Ellen Wald Parkinson's Disease 
Fund has supported research and clinical programs at the University 
Hospital and the Hospital's Department of Neurology. Mrs. Wald is 
shown here with her son, Stephen Wald (left) and Dr. Robert Feldman 
(right) during the dedication of the Harold and Ellen Wald Inpatient 
Neurology Unit at the University Hospital. 
ease may be caused by prolonged ex-
posure to low levels of an environ-
mental toxin. It also turned out that 
in experimental animals, the toxic ef-
fect of MPTP was blocked by 
Deprenyl. If natural Parkinson's dis-
ease is caused by an environmental 
chemical like MPTP, Deprenyl 
might prevent the production of the 
toxic agent and protect the suscep-
tible brain cells. 
In addition, some researchers 
believe that the brain cell degenera-
tion in Parkinson's disease may be in-
flicted by other chemicals generated 
by the degradation of Dopamine by 
the MAO. The administration of 
Deprenyl might be protective in this 
way too, since i t blocks the MAO, as 
we discussed previously. 
So far there is insufficient informa-
tion to determine if Deprenyl can in 
fact slow down the progression of 
Parkinson's disease. A multi-center 
trial studying this hypothesis is now 
taking place in the United States and 
Canada, but results w i l l not be avail-
able for at least two years. 
In conclusion, Deprenyl is a valu-
able adjunct to long-term levodopa 
therapy. It is unclear if i t w i l l slow 
the progression of Parkinson's dis-
ease. It is not available by prescrip-
tion in the United States but we 
hope i t w i l l be approved in the near 
future. 
For further information please 
contact the Information and 
Referral Center at (617) 638-8466. 
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Parkinson Center Happenings 1989 
January 
Cathi Thomas, R.N., M.S., and Linda Perry, R.N., visited the Concord 
support group and presented an update on Parkinson's disease. 
Dr. David Staskin of the U H Urology Department visited the South 
Shore Hospital Parkinson Support Group and presented a lecture on 
urological problems with PD. 
February 
Dr. Peter Mosbach spoke to members of the Newton Wellesley support 
group about coping with Parkinson's disease. Linda Perry, R.N., 
presented a lecture on medications used for Parkinson patients to the 
nursing staff at the University Hospital. 
Dr. Peter Mosbach gave a presentation on "Hallucinations in Parkinson's 
Disease" at Neurology Grand Rounds at the Boston VA Medical Center. 
March 
Dr. Robert Feldman presented a talk on Ufestyles and Parkinson's disease 
at the South Shore Hospital support group. 
Dr. Marie Saint-Hilaire was interviewed by Boston radio station WROR 
and presented an update on Parkinson's disease. 
Dr. Marie Saint-Hilaire and Linda Perry, R.N., were interviewed on radio 
station WODS on the role of the new day program. 
April "Parkinson's Awareness Month" 
Cathi Thomas, R.N., M.S., Edith Devegvar, LICSW, and Dr. Peter 
Mosbach presented a conference entitled "Sharing and Caring" at 
Norwood Hospital. In attendance were representatives from most of 
the support groups in New England. 
Ms. Jean Dietz, a columnist for the Boston Globe, visited the Parkinson's 
Day Program at the University Hospital. 
Cathi Thomas, R.N., M.S., attended a meeting at the South Shore 
Hospital and presented an update on Parkinson's disease. 
Linda Perry, R.N., presented a lecture to Welch Home Care services 
on management of the Parkinson patient. 
Dr. Robert Feldman attended an International Symposium in London, 
organized by Merck, Sharpe and Doehme, where he presented the results 
of a study comparing controlled-release and standard Sinemet in patients 
with stage U and early stage HI Parkinson's disease. 
RESEARCH 
UPDATE 
On April 27, Dr. Robert Feldman 
presented a paper concerning re-
search done by the Parkinson team 
at Boston University Medical Center 
on Sinemet CR at the International 
Symposium on Therapeutic Ap-
proaches in the Treatment of 
Parkinson's Disease. The sym-
posium, which took place in London, 
was sponsored by Merck, Sharp and 
Doehme Pharmaceutical Co. The re-
search examined a group of in-
dividuals with stage two and stage 
three Parkinson's disease and their 
response to Sinemet CR (controlled-
release form) as compared with stand-
ard Sinemet. Results of this study 
will soon be pubHshed in the 
journal Neurology. 
Pergolide, a new dopamine 
agonist, has been approved by the 
Food and Drug Administration and 
will be available by prescription July 
1st. Clinical trials of this medication 
have been ongoing at Boston Univer-
sity Medical Center under the direc-
tion of Dr. Feldman since 1982. 
The American Parkinson Disease 
Association has awarded a $20,000 
grant to the Department of Neurol-
ogy at Boston University Medical 
Center to initiate a pilot study look-
ing at the incidence and prevalence 
of Parkinson's disease and identify-
ing possible environmental risk fac-
tors associated with the etiology. 
The Framingham Heart Study 
population as well as the population 
at BUMC will be studied. 
May 
Dr. Robert G. Feldman presented medical grand rounds at Beverly 
Hospital on Parkinson's disease. 
Linda Perry, R.N., spoke to Curry College nursing students on 
Parkinson's disease. 
Mr. John Hogan of Sandoz Pharmaceuticals presented an in-service on a 
new patient education series called PATH. For further information call 
the Center. 
Cathi Thomas, R.N., M.S., visited the Norwood support group and 
observed their unique exercise and dance program. 
Dr. Marie Saint-Hilaire presented an update on Parkinson's disease at the 
Emerson Hospital support group in Concord, MA. 
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Mass. Chapter News 
by Jeanne Murphy 
I would like to take this opportunity 
to welcome you to the Chapter 
column. As many of you know, the 
Massachusetts Chapter of the 
American Parkinson Disease Associa-
tion was established in May of 1987. 
We are one of several chapters located 
throughout the United States. A 
primary role of the chapter is to raise 
funds for research, to increase public 
awareness of Parkinson's disease, and 
to assist the Information and Referral 
Center w i t h their programs. At 
present the Chapter forwards 60 per-
cent of funds raised to the APDA head-
quarters in New York while the 
remaining 40 percent is kept in the 
state for local programs. APDA uses 
these funds to further national 
programs in patient care and research. 
The Chapter is strictly made up of 
volunteers, and, as wi th any other non-
profit organization, we can always use 
Young 
Parkinsonian's 
Counseling Group 
by Peter Mosbach, Ph.D. 
Young Parkinsonians often have con-
cerns that differ from those of older in-
dividuals wi th Parkinson's disease. 
For example, younger individuals may 
be dealing wi th issues related to work 
and raising a family. In order to meet 
the needs of younger patients, I have 
started a counseling group which w i l l 
meet on a monthly basis. The group 
provides an opportunity for patients 
and family members to share their ex-
periences and express their concerns. 
The group is designed to offer a suppor-
tive environment where individuals 
feel comfortable helping others by dis-
cussing their experiences in coping 
wi th Parkinson's disease. 
One group has recently started in 
the South Shore area and meets bi-
monthly in Weymouth. If there is suf-
ficient interest, a second group w i l l be 
started which would be convenient to 
individuals living north of Boston. If 
you would like additional information 
about the group please contact me at 
(617)266-1565. 
more volunteers. In the past two 
years we have coordinated three 
walkathons and held a large sym-
posium. Recently, wi th much help 
from the Norwood Support Group, we 
invited all support group leaders from 
New England to a workshop for group 
leaders to share ideas. Our various ac-
tivities have included a murder 
mystery ball held April 1st, and as we 
went to press, we have been con-
centrating on our largest fundraiser, a 
"Night at the Pops," on June 18, 1989. 
As President of the Chapter, I en-
courage all of you to become members 
of the chapter and hope that many of 
you can take an active role. It is wi th 
your involvement that we can "Ease 
the Burden and Find the Cure". 
With Best Wishes, 
Jeanne Murphy, President 
Chapter News 
officers 
Jeanne Murphy, President 
Suzanne Morin and Midge 
Stahoviak, Vice Presidents 
Robert Sartini, Treasurer 
Cathi Thomas, Secretary 
Sophia Camann, Chairperson of 
Fundraising 
1989 Michel Monnot-Sandoz 
Pharmaceuticals Walkathon 
On April 15, 125 participants 
gathered under the red and white 
tent to participate in the third an-
nual walkathon to raise funds for 
Parkinson's disease. The par-
ticipants donned tee-shirts provided 
to help publicize the event. Over 
$5,000 was raised solely by in-
dividuals who came to walk the five-
mile route. We would like to take 
this opportunity to thank all of the 
walkers and their sponsors in 
making this a successful event. We 
would like to thank the following 
companies and/or individuals for 
their time and donations: 
John Hancock Financial Services 
Matt Garrett's Restaurants 
Ultima Cosmetics 
Nick's Comedy Stop 
Robert G. Feldman 
Trophies and Awards by 
John Murphy 
Sandoz Pharmaceuticals 
Mr. John Hogan 
Norma McDonough 
Walkers receive T-shirts and register for the Third Annual Michel Monnot-Sandoz 
Pharmaceuticals APDA Walkathon. 
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The Information and Referral Center Staff. From left to right: Robert G. Feldman, M.D.; Jeanne 
Murphy; Marie Saint Hilaire, M.D.; Linda Perry, R.N.; Peter Mosbach, Ph.D.; and Cathi Thomas, R.N., 
M.S. 
Support Groups 
Massachusetts, like other New England states, is fortunate to have a strong net-
work of support groups. Many individuals are often hesitant to attend support 
group meetings, but once they do attend, they often find these meetings to be 
beneficial. In general, support groups offer a great opportunity for Parkinsonians 
and family members to share common experiences and helpful hints on living 
wi th Parkinson's disease. There is also a strong educational component to these 
groups. It is well known that individuals who understand their condition adjust 
better to activities of daily living. The most important aspect of support groups 
is the opportunity to socialize. Many individuals wi th Parkinson's disease and 
their spouses become isolated due to a decrease in socialization. 
In this first issue, we list the support group names and contact persons. We 
would like to share any information from support groups in future issues and 
therefore w i l l devote a column just for this purpose. 
Emerson Hospital Support Group 
9 Old Acre Corner 
Concord, MA 01742 
Contact: Linda Moran 
617-369-1400, ext. 416 
Newton-Wellesley 
Parkinson's Support Croup 
Angelside Road #47-4 
Waltham, MA 01742 
Contact: Dorothy Halpern 
617-894-5598 
Norwood Hospital Parkinson's 
Support Croup Inc. 
725 Neponset Street 
Norwood, MA 02062 
Contact: Dorrie Hefferman 
617-762-2754 
Shaughnessy Hospital 
Dove Avenue 
Salem, MA 01970 
Contact: Kathy Sloss 
617-745-9000, ext. 122 
Parkinson's Support Croup of 
Cape Cod 
16 Katy Hatch Road 
Falmouth, M A 02540 
Contact: Dr. Christopher Mamonas 
508-896-5587 
Parkinson's Support Croup of 
Greater Springfield 
VNA 600 Berkshire Avenue 
Springfield, M A 01109 
Contact: Edith Dorang 
413-781-5070 
North Shore 
Parkinson's Support Croup 
137 Winter Street 
Saugus, M A 01906 
Contact: Mary Unger 
617-233-4868 
Hehrew Rehahilitation Center 
for the Aged 
1200 Centre Street 
Roslindale, M A 02131 
Contact: Olga T. Hurley 
617-325-8000, ext. 380 
PEP of Plymouth Area 
Plymouth Council of Aging 
130 Court Street 
Plymouth, M A 02360 
Contact: Lee Anderson 
508-746-4030 
South Shore ~—~-
Parkinson's Support Croup 
Sparks 
80 Mediterranean Drive 
Weymouth, M A 02188 
Contact: Dick Goldstein 
617-331-2690 
Southwood Community Hospital 
Parkinson's Support Croup 
111 Dedham Street 
Norfolk, M A 02056 
Contact: Joan Engstrom 
508-543-8859 
Parkinson's Society of 
Greater Worcester 
47 Harvard Street 
Worcester, M A 01608 
Contact: Andrew McCarthy 
508-757-0424 
Charlton Memorial Hospital 
Parkinson's Support Croup 
Highland Avenue 
Fall River, M A 02720 
Contact: Kathryn CuUen 
401-722-6000 
Andover Parkinson's Disease 
Support Croup 
Andover Council on Aging 
36 Bartlett Street 
Andover, MA 01810 
Contact: Elizaheth Leed 
508-470-3800 
Progress Notes 
A Report from the Parkinson's Disease Center 
at Boston University Medical Center 
720 Harrison Avenue, Suite 707 
Boston, MA 02118-2393 
